InvestorsHub Logo

UFO

Followers 12
Posts 1104
Boards Moderated 0
Alias Born 03/27/2003

UFO

Member Level

Re: None

Wednesday, 10/04/2017 7:57:41 AM

Wednesday, October 04, 2017 7:57:41 AM

Post# of 8922
Capricor Drug Showed Meaningful Improvements in DMD; Shares Up
By Andrew Kostic
(Bloomberg) -- Capricor Therapeutics reported that teens and young men in the advanced stages of Duchenne muscular dystrophy (DMD) experienced meaningful improvements in cardiac and upper limb function after a single dose of Capricor’s lead investigational product, CAP-1002.
Capricor cites first six months of follow-up data from the randomized 12-month Phase I/II HOPE clinical trial
Shares up 14% pre market
CAPR US Equity
Graphic Dashboard»
Related ticker:
CAPR US (Capricor Therapeutics Inc)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CAPR News